SEC 13F Intelligence

Palo Alto Investors LP / IMMU

Palo Alto Investors LP’s Immunomedics Inc Position

Does Palo Alto Investors LP own Immunomedics Inc (IMMU)? Not currently — the last reported position was 4.85M shares worth $413M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$413M
Q3 2020
Shares
4.85M
% of Portfolio
+22.65%
Quarters Held
7
position exited

Position History IMMU

Reported value by quarter
Q4 ’18: $74MQ4 ’18Q1 ’19: $123MQ1 ’19Q2 ’19: $93MQ2 ’19Q3 ’19: $82MQ3 ’19Q1 ’20: $71MQ1 ’20Q2 ’20: $184MQ2 ’20Q3 ’20: $413MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20204.85M$413M+22.65%
Q2 20205.18M$184M+11.03%
Q1 20205.29M$71M+5.97%
Q3 20196.18M$82M+5.46%
Q2 20196.68M$93M+4.50%
Q1 20196.38M$123M+5.11%
Q4 20185.19M$74M+3.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of IMMU.